Home > Boards > US Listed > Biotechs >

Neptune tech and Bio-Resources (NEPT)

Add NEPT Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 2/22/2018 6:17:11 PM - Followers: 29 - Board type: Free - Posts Today: 0 

I first heard about this stock when it was trading at the $2.32 mark a few weeks ago. Now we're hearing that more institutional buying and high profile firms are getting ready to take positions. That, in-turn, should lead to even more buying by retail investors. It's the stock snowball and visibility effect and this company deserves it 

About Neptune

Neptune Technologies & Bioressources Inc. researches, develops and commercializes proprietary bioactive ingredients and products with superior added-value and clinically proven health benefits. The Company extracts a range of bioactive ingredients such as novel proprietary omega-3 phospholipids from abundant yet underexploited marine biomass including Krill, a cold deep water zooplankton. Neptune's first commercially available product is Neptune Krill Oil (NKO®), which represents the only clinically proven and scientifically acknowledged marine omega-3 phospholipids with cardiovascular, cognitive and anti-inflammatory benefits for human applications and which exhibits unmet safety, purity and stability and consequently denoting a new level of excellence in omega-3 standards.

Neptune is pursuing market opportunities in the nutraceutical market including dietary supplements and functional foods. The Company is benefiting from opportunities in the pharmaceutical market through its pharmaceutical subsidiaries Acasti Pharma and NeuroBioPharm (including medical food, over-the-counter and prescription drug applications).

The Mission of Neptune is to:

  • Research, Develop and Commercialize Novel Marine Bioactive Ingredients
  • Pursue opportunities in the nutraceutical markets
    • Dietary Supplement
    • Functional Food
  • Exploit pharmaceutical applications
    • Subsidiary Acasti Pharma Inc: Cardiovascular diseases
    • Subsidiary NeuroBioPharm Inc.: Neurodegenerative diseases
  • Validate Superiority, Safety & Effectiveness
  • Protect Intellectual Property
  •   Enter Commercialization Alliances and Partnership Licenses

Promising results from A new cholesterol drug have helped call attention to Neptune, which is aiming for cholesterol/hyperlipidemia's ultimate prize, but unlike most companies dealing with clinical studies and regulatory approvals, Neptune is a revenue generating company whose products are already marketed and distributed in over 20 countries worldwide.

The Versant Partners' report, subtitled: "Krill oil franchise poised to outperform in multiple consumer and medical markets" features a few key points of note.

With NEPT's fiscal year end being February, Mr. Loe is calling for:

* F2012 revenues of $21.79 million and earnings $4.34 million ($0.09 EPS)
* F2013 revenues of $32.39 million and earnings of $8.81 million ($0.17 EPS)
* F2014 revenues of $45.37 million and earnings of $15.69 million ($0.30 EPS)
Loe cited management plans to meet forecasted demand by increasing current plant production from 130 thousand kilograms of krill oil per year to 430 thousand kilograms per year by 2015, a 300% production increase.
The report pinned its share price targets not only on the business Neptune has in hand, but also its future. By far, the biggest foundation Mr. Loe constructed on which to base his conclusions came from his meticulous research into the product itself - Neptune Krill Oil or NKO as it is branded on the market - and all its further refined products, such as Acasti's drug candidate called 'CaPre'.

Along the way, Loe also gives a significant nod to the functional food alliances Neptune developed with Yoplait - which is 50% owned by General Mills - and the food manufacturing behemoth, Nestle.

Mr. Loe wrote that both Yoplait and Nestle "should conclude development," of their research into Neptune Krill Oil by the end of the current year and that assuming all goes well, the sales of krill-oil infused food products by these giants would be a major revenue driver for Neptune in 2013/14  About Acasti

Acasti Pharma is developing safe and effective pharmaceutical and medical applications with an initial focus on cardiovascular disease by leveraging the intellectual property, clinical data and know how developed by Neptune Technologies. The Company is advancing a portfolio of bioactive ingredients of proprietary novel omega-3 phospholipids through the pharmaceutical development pathway which includes prescription medical foods (MF), over-the-counter products (OTC), and prescription drugs (Rx). Phospholipids are the major component of cell membranes and essential for all vital cell processes. They are one of the principle constituents of High Density Lipoprotein (good cholesterol) and play, as such, an important role in modulating cholesterol efflux.

Acasti Pharma's proprietary novel phospholipids carry and functionalize the polyunsaturated omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) stabilized by potent antioxidants. Evidence has demonstrated the anti-inflammatory properties of EPA and DHA regulating important biological functions including degenerative, arthritic, circulatory, digestive, and brain diseases. Delivering omega-3s functionalized on phospholipids helps optimize the omega-3 fatty acid therapeutic benefits. Potent antioxidants contribute to proper physiological regulation preventing free radical cellular damage, a common pathway for cardiovascular disease and inflammation as well as neurodegenerative disease 


Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
NEPT News: Report of Foreign Issuer (6-k) 02/14/2018 04:48:11 PM
NEPT News: Report of Foreign Issuer (6-k) 02/14/2018 04:13:58 PM
NEPT News: Amended Statement of Ownership (sc 13g/a) 02/14/2018 02:49:06 PM
NEPT News: Amended Statement of Ownership (sc 13g/a) 02/13/2018 04:21:14 PM
NEPT News: Report of Foreign Issuer (6-k) 02/12/2018 08:02:13 AM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
#239   Did some research. Some outfit downgraded to Rogue3 02/22/18 06:17:11 PM
#238   wondering the same kanonman 02/22/18 12:57:14 PM
#237   Why is this hitting new lows? Rogue3 02/22/18 12:43:07 PM
#236   I just sent this to Admin: kayakhigh 02/12/18 07:38:16 PM
#235   Yep - I bought in before Christmas - kayakhigh 02/12/18 07:36:17 PM
#234   NEPT is no longer a bulk krill oil bucksynthesis 01/23/18 08:01:51 PM
#233   Is this OK for the oceans? In kayakhigh 01/23/18 06:58:16 PM
#232 Can bucksynthesis 01/11/18 01:47:33 AM
#231   Gapping up at open ... i can find MCA 01/04/18 08:53:40 AM
#230   $5 $10 Summer swing wealththrupennies 01/03/18 06:00:55 PM
#229   verrrry pretty!!! a chart worth framing! kanonman 01/01/18 06:42:59 PM
#228   NEPT This is crazy....does anyone have a link mdstocks 01/01/18 06:40:10 PM
#227   a master piece!!!! TrendTrade2016 12/30/17 09:14:35 AM
#226   * * $NEPT Video Chart 12-29-17 * * ClayTrader 12/29/17 05:23:17 PM
#225   NEPT.TO breaking 3 bucks!!! TrendTrade2016 12/29/17 03:15:22 PM
#224 blowing up !! TrendTrade2016 12/29/17 11:45:52 AM
#223   Article from TheStreet on NEPT and their cannabis bucksynthesis 12/16/17 12:20:27 AM
#222   Oh well, no posters and the stock is losing money here 12/12/17 11:32:03 AM
#221   NEPT the best canadian cannabis oil play out there.. TrendTrade2016 12/09/17 04:19:02 AM
#220   watch how the pros make money u might TrendTrade2016 12/09/17 04:17:52 AM
#219   THIS IS GOING TO FLY!!! PROFITABLE COMPANY WITH moneyjunkey 12/04/17 07:19:54 AM
#218   POS SCAM DONT BUY General Grievous 11/29/17 11:03:17 AM
#217   Well, NEPT hit a snag today. I guess losing money here 11/28/17 03:15:26 PM
#216   ALL BUY MYSELF!!! GO NEBT!! MONSTER WEED PLAY!! TrendTrade2016 11/28/17 10:37:46 AM
#215   les like H-funds moving this puppy now ... . Den 11/28/17 09:57:16 AM
#214   do not sell/ they are into the canadian TrendTrade2016 11/27/17 01:11:30 PM
#213   Hey TradeTrend2016, I bought this dud over 5 losing money here 11/27/17 01:09:29 PM
#212   undiscovered Canadian weed play ready for lift off//34 TrendTrade2016 11/26/17 07:13:19 AM
#211   I discovered that this company got rid of losing money here 11/21/17 07:20:19 PM
#210   I realized that the day I bought it. TXplowgirl 11/21/17 01:37:18 PM
#209   Hello TX, you've made a wrong choice in losing money here 11/21/17 11:19:42 AM
#208   Yep, been there done that. I'm taking a TXplowgirl 11/06/17 05:07:55 PM
#207   I hope there is some news that is losing money here 11/04/17 03:43:24 PM
#206   Had a friend recommend NEPT to me. Has TXplowgirl 11/02/17 11:09:10 PM
#205   Website link: 2fer1 10/07/16 10:29:07 AM
#204   Some news here today: 2fer1 10/07/16 10:03:10 AM
#203   * * $NEPT Video Chart 10-06-16 * * ClayTrader 10/06/16 05:25:32 PM
#202   Can anyone confirm these numbers? merushn 07/29/16 10:14:48 AM
#201   How long is this stock going to take losing money here 07/22/16 12:15:24 AM
#200 total guchu 07/15/16 09:03:49 AM
#199   Conference call July 12, 2016 8 AM EST!! moneyjunkey 06/30/16 11:11:05 AM
#198   Great company, great product, great guidance!!! moneyjunkey 06/03/16 10:58:49 AM
#197   $NEPT Daily & Weekly Chart http://stock $Pistol Pete$ 05/30/16 04:40:26 PM
#196   NEPT PR this morning. Business better than expected Joe_NY 11/06/15 11:58:18 AM
#195   Wow, the earnings look good. Plus a lot Joe_NY 10/16/15 07:48:49 PM
#194   MAYBE N0 FAITH IN THE NEW CEO!!! Smitty99 12/04/14 03:48:11 PM
#193   $NEPT Neptune: Phase 2 Topline Win Welcomes Neptune maytepper 10/03/14 11:00:24 AM
#192   All out at 2.27. Looks like the conference rocketeer357 09/11/14 10:01:34 AM
#191   Back in here at 1.88 rocketeer357 09/04/14 06:51:25 AM
#190   Dumped approx 2.04 this morning at market open THREE-DAY-TRADER 08/07/14 12:48:46 PM